Viatris [VTRS] vs Zoetis [ZTS] Detailed Stock Comparison
Viatris
NASDAQ
Loading...
Zoetis
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Viatris wins in 8 metrics, Zoetis wins in 12 metrics, with 0 ties. Zoetis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Viatris | Zoetis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 235.80 | 25.36 | Zoetis |
| Price-to-Book Ratio | 0.80 | 13.14 | Viatris |
| Debt-to-Equity Ratio | 94.78 | 137.01 | Viatris |
| PEG Ratio | -2.36 | 23.24 | Viatris |
| EV/EBITDA | 6.34 | 17.91 | Viatris |
| Profit Margin (TTM) | -24.57% | 27.83% | Zoetis |
| Operating Margin (TTM) | 9.95% | 40.20% | Zoetis |
| EBITDA Margin (TTM) | 9.95% | 40.20% | Zoetis |
| Return on Equity | -19.77% | 52.77% | Zoetis |
| Return on Assets (TTM) | 2.30% | 15.37% | Zoetis |
| Free Cash Flow (TTM) | $1.94B | $2.30B | Zoetis |
| Dividend Yield | 6.19% | 1.11% | Viatris |
| 1-Year Return | -9.01% | -16.11% | Viatris |
| Price-to-Sales Ratio (TTM) | 0.88 | 6.96 | Viatris |
| Enterprise Value | $26.09B | $70.67B | Zoetis |
| EV/Revenue Ratio | 1.85 | 7.53 | Viatris |
| Gross Profit Margin (TTM) | 37.21% | 73.62% | Zoetis |
| Revenue per Share (TTM) | $12 | $21 | Zoetis |
| Earnings per Share (Diluted) | $-2.93 | $5.81 | Zoetis |
| Beta (Stock Volatility) | 0.90 | 0.88 | Zoetis |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Viatris vs Zoetis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Viatris | -0.75% | 9.38% | 18.81% | 20.71% | -2.30% | -14.57% |
| Zoetis | 1.51% | 4.59% | 0.82% | -3.89% | -1.51% | -5.23% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Viatris | -9.01% | 0.38% | -33.65% | -79.40% | -39.51% | -41.64% |
| Zoetis | -16.11% | -9.09% | -2.69% | 242.31% | 396.97% | 396.97% |
Performance & Financial Health Analysis: Viatris vs Zoetis
| Metric | VTRS | ZTS |
|---|---|---|
| Market Information | ||
| Market Cap | $12.46B | $65.30B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 10,505,913 | 4,111,510 |
| 90 Day Avg. Volume | 8,608,808 | 3,459,870 |
| Last Close | $10.61 | $167.10 |
| 52 Week Range | $6.85 - $13.55 | $139.70 - $200.33 |
| % from 52W High | -21.70% | -16.59% |
| All-Time High | $76.69 (Apr 20, 2015) | $249.27 (Dec 27, 2021) |
| % from All-Time High | -86.17% | -32.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.06% | 0.04% |
| Quarterly Earnings Growth | -0.06% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.25% | 0.28% |
| Operating Margin (TTM) | 0.10% | 0.40% |
| Return on Equity (TTM) | -0.20% | 0.53% |
| Debt to Equity (MRQ) | 94.78 | 137.01 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $13.36 | $11.21 |
| Cash per Share (MRQ) | $0.69 | $3.28 |
| Operating Cash Flow (TTM) | $2.06B | $2.93B |
| Levered Free Cash Flow (TTM) | $4.91B | $2.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | 6.19% | 1.11% |
| Last 12-Month Dividend | $0.60 | $1.86 |
Valuation & Enterprise Metrics Analysis: Viatris vs Zoetis
| Metric | VTRS | ZTS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 235.80 | 25.36 |
| Forward P/E | 4.00 | 23.24 |
| PEG Ratio | -2.36 | 23.24 |
| Price to Sales (TTM) | 0.88 | 6.96 |
| Price to Book (MRQ) | 0.80 | 13.14 |
| Market Capitalization | ||
| Market Capitalization | $12.46B | $65.30B |
| Enterprise Value | $26.09B | $70.67B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.85 | 7.53 |
| Enterprise to EBITDA | 6.34 | 17.91 |
| Risk & Other Metrics | ||
| Beta | 0.90 | 0.88 |
| Book Value per Share (MRQ) | $13.36 | $11.21 |
Financial Statements Comparison: Viatris vs Zoetis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VTRS | ZTS |
|---|---|---|
| Revenue/Sales | $3.25B | $2.22B |
| Cost of Goods Sold | $2.09B | $622.00M |
| Gross Profit | $1.16B | $1.60B |
| Research & Development | $222.00M | $157.00M |
| Operating Income (EBIT) | $-8.90M | $846.00M |
| EBITDA | $556.50M | $991.00M |
| Pre-Tax Income | $-3.10B | $810.00M |
| Income Tax | $-55.00M | $179.00M |
| Net Income (Profit) | $-3.04B | $631.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VTRS | ZTS |
|---|---|---|
| Cash & Equivalents | $755.00M | $1.72B |
| Total Current Assets | $9.62B | $5.88B |
| Total Current Liabilities | $5.72B | $3.39B |
| Long-Term Debt | $14.35B | $5.40B |
| Total Shareholders Equity | $15.65B | $4.66B |
| Retained Earnings | $227.90M | $12.38B |
| Property, Plant & Equipment | $265.90M | $6.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VTRS | ZTS |
|---|---|---|
| Operating Cash Flow | $-2.44B | $567.00M |
| Capital Expenditures | $11.30M | N/A |
| Free Cash Flow | $459.10M | $438.00M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-175.40M | $-443.00M |
Short Interest & Institutional Ownership Analysis
| Metric | VTRS | ZTS |
|---|---|---|
| Shares Short | 37.17M | 7.85M |
| Short Ratio | 4.46 | 2.67 |
| Short % of Float | 0.04% | 0.02% |
| Average Daily Volume (10 Day) | 10,505,913 | 4,111,510 |
| Average Daily Volume (90 Day) | 8,608,808 | 3,459,870 |
| Shares Outstanding | 1.19B | 448.47M |
| Float Shares | 1.16B | 442.37M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.83% | 0.98% |
Dividend Analysis & Yield Comparison: Viatris vs Zoetis
| Metric | VTRS | ZTS |
|---|---|---|
| Last 12-Month Dividend | $0.60 | $1.86 |
| Last 12-Month Dividend Yield | 6.19% | 1.11% |
| 3-Year Avg Annual Dividend | $0.52 | $1.63 |
| 3-Year Avg Dividend Yield | 1.17% | 0.24% |
| 3-Year Total Dividends | $1.56 | $4.90 |
| Ex-Dividend Date | Aug 22, 2025 | Apr 21, 2025 |